Vertex has stepped up its interest in kidney disease over the past year, moving inaxaplin into a phase 2/3 AMKD trial at the start of April and inking a $4.9 billion deal to buy Alpine Immune ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

The founder and CEO of IPO-bound fintech Klarna took to X to once again explain why his company ditched Salesforce’s flagship CRM product about a year ago in favor of its own homegrown AI system.

It all occurred when an artist who allegedly works at Marvel reportedly mass-leaked their concept art for Avengers: Doomsday showcasing the movie's superheroes and villains in different scenarios.

A Dance That Sparked Debate The short clip of Bellucci dancing, while seemingly innocuous, has prompted a mix of admiration, nostalgia, and discomfort among social media users. One user tweeted ...

Cash and Cash Equivalents: Over $296 million at quarter end. Vertex Inc (NASDAQ:VERX) reported a 15.2% year-over-year increase in revenue for Q4 2024, reaching $178.5 million. Cloud revenue growth ...

The end of the Vertex-Verve collaboration comes as investors are reevaluating once sky-high expectations for the gene editing industry as commercial realities set in. Shares of Verve and top companies ...

WASHINGTON — US President Donald Trump's official social media accounts posted an apparent AI-generated video depicting war-ravaged Gaza rebuilt into a seaside resort, replete with a towering golden ...

When Vertex Pharmaceuticals announced last month that its pain pill had received approval from the U.S. Food and Drug Administration (FDA), it marked a major breakthrough in the hunt for new ...

Travis Gettys is a senior editor for Raw Story based in northern Kentucky. He previously worked as a web editor for WLWT-TV and a contributing writer for the Kentucky Enquirer, and he also wrote ...